Sotera Health Company (NAS: SHC) Stock Analysis & Fundamentals | ScreenerHero

Create free account

SHCSotera Health Company

NAS · US · Healthcare · Diagnostics & Research · soterahealth.com

17.75USD-2.85%Mkt Cap: 5.06B $P/E: 43.291d ago

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segment…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$197.88BUSDP/E 29.3

Danaher Corporation

$144.26BUSDP/E 39.4

$45.26BUSDP/E 43.7

IDEXX Laboratories, Inc.

$44.76BUSDP/E 41.7

Agilent Technologies, Inc.

$37.13BUSDP/E 26.4

Waters Corporation

$36.23BUSDP/E 46.9

IQVIA Holdings Inc.

$34.42BUSDP/E 25.7

$28.24BUSDP/E 33.9

Mettler-Toledo International Inc.

$26.47BUSDP/E 30.8

Quest Diagnostics Incorporated

$23.32BUSDP/E 23.3

Labcorp Holdings Inc.

$23.24BUSDP/E 25.1

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.21BUSDP/E 27.6

$12.29BUSDP/E 53.0

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.40BUSDP/E 22.0

BillionToOne, Inc.

$5.99BUSDP/E 241.3

Twist Bioscience Corporation

$4.72BUSDP/E 54.8

DiaSorin S.p.A.

$3.73BUSDP/E 26.3

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.70BUSDP/E 43.3

Personalis, Inc.

Diagnostyka S.A.

$1.46BUSDP/E 22.1

Clínica Baviera, S.A.

$996.45MUSDP/E 20.9

OPKO Health, Inc.

Castle Biosciences, Inc.

$653.57MUSDP/E 42.6

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$292.59MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap5.06B $

Enterprise Value7.13B $

Revenue (TTM)1.19B $

Gross Profit645.53M $

Net Income (TTM)77.95M $

Revenue/Share4.183 USD

Last Price17.75 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees3.0K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)43.29

P/E (Forward)17.23

PEG1.31

EV/EBITDA12.73

EV/Revenue6.00

P/S4.38

P/B8.37

EPS (TTM)0.41

EPS (Forward)1.06

52W Range

10.9476% of range19.85

52W High19.85 USD

52W Low10.94 USD

Profitability

Gross Margin55.48%

Oper. Margin31.26%

EBITDA Margin47.11%

Profit Margin6.70%

ROE12.86%

ROA2.39%

Growth

Revenue Growth10.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF287.19M $

CapEx (TTM)138.02M $

FCF Margin12.18%

FCF Yield2.86%

Net Debt1.96B $

Net Debt/EBITDA3.49

Balance Sheet

Debt/Equity3.75

Current Ratio2.82

Quick Ratio2.36

Book Value/Sh2.183 USD

Cash/Share1.102 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.7 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)20.44 USD

Upside (mean)+15.2%

Target Range16.00 USD – 24.00 USD

$16.00+15.2% to mean$24.00

# Analysts9

Ownership

Shares Out.285.17M

Float191.82M

Insiders2.36%

Institutions90.28%

Short Interest

Short Ratio6.1d

Short % Float6.49%

Short % Out.5.62%

Shares Short16.02M

Short (prev mo.)18.84M

Technical

SMA 5016.31 (+8.8%)

SMA 20016.38 (+8.4%)

Beta1.77

S&P 52W Chg20.25%

Avg Vol (30d)2.49M

Avg Vol (10d)2.95M

Technical Indicators

RSI (14)57.4

MACD0.5592

MACD Signal0.5751

MACD Hist.-0.0159

BB Upper19.34 USD

BB Middle17.36 USD

BB Lower15.37 USD

BB Width22.85%

ATR (14)0.5161 USD

Vol Ratio (20d)1.25x